Abstract
The serotonin transporter gene (SLC6A4, MIM 182138) is a candidate gene in autistic disorder based on neurochemical, neuroendocrine studies and the efficacy of potent serotonin transporter inhibitors in reducing ritualistic behaviors and related aggression. An insertion/deletion polymorphism (5-HTTLPR) in the promoter region and a variable number of tandem repeat polymorphism (VNTR) in the second intron, were previously identified and suggested to modulate transcription. Six previous family-based association studies of SLC6A4 in autistic disorder have been conducted, with four studies showing nominally significant transmission disequilibrium and two studies with no evidence of nominally significant transmission disequilibrium. In the present study, TDT was conducted in 81 new trios. A previous finding of transmission disequilibrium between a haplotype consisting of the 5-HTTLPR and intron 2 VNTR was replicated in this study, but not preferential transmission of 5-HTTLPR as an independent marker. Because of inconsistent transmission of 5-HTTLPR across studies, SLC6A4 and its flanking regions were sequenced in 10 probands, followed by typing of 20 single nucleotide polymorphisms (SNPs) and seven simple sequence repeat (SSR) polymorphisms in 115 autism trios. When individual markers were analyzed by TDT, seven SNP markers and four SSR markers (six SNPs, 5-HTTLPR and the second intron VNTR from promoter 1A through intron 2 of SLC6A4, one SSR from intron 7 of SLC6A4, one SNP from the bleomycin hydrolase gene (BLMH, MIM 602403) and one SSR telomeric to BLMH) showed nominally significant evidence of transmission disequilibrium. Four markers showed stronger evidence of transmission disequilibrium (TDTmax P = 0.0005) than 5-HTTLPR.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bailey A, Le Couteur A, Gottesman I, Bolton P, Simonoff E, Yuzda E et al. Autism as a strongly genetic disorder: evidence from a British twin study Psychol Med 1995 25: 63–78
Bailey A, Phillips W, Rutter M . Autism: towards an integration of clinical, genetic, neuropsychological, and neurobiological perspectives J Child Psychol Psychiatry 1996 37: 89–126
Lord C, Cook E, Leventhal B, Amaral D . Autism spectrum disorders Neuron 2000 28: 355–364
Cook EH . Genetics of autism Ch Adolesc Psychiatr Clin NA 2001 10: 333–350
Risch N, Spiker D, Lotspeich L, Nouri N, Hinds D, Hallmayer J et al. A genomic screen of autism: evidence for a multilocus etiology Am J Hum Genet 1999 65: 493–507
Pritchard JK . Are rare variants responsible for susceptibility to complex diseases? Am J Hum Genet 2001 69: 124–137
Schain RJ, Freedman DX . Studies on 5-hydroxyindole metabolism in autistic and other mentally retarded children J Pediatrics 1961 58: 315–320
Cook E, Rowlett R, Jaselskis C, Leventhal B . Fluoxetine treatment of patients with autism and mental retardation J Am Acad Child Adolesc Psychiatry 1992 31: 739–745
Gordon C, State R, Nelson J, Hamburger S, Rapoport J . A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder Arch Gen Psychiatry 1993 50: 441–447
McDougle C, Naylor S, Cohen D, Volkmar F, Heninger G, Price L . A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder Arch Gen Psychiatry 1996 53: 1001–1008
Cook E, Leventhal B . The serotonin system in autism Curr Opin Pediatr 1996 8: 348–354
Ramamoorthy S, Bauman AL, Moore KR, Han H, Yang-Feng T, Chang AS et al. Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization Proc Natl Acad Sci USA 1993 90: 2542–2546
Gelernter J, Pakstis AJ, Kidd KK . Linkage mapping of serotonin transporter protein gene SLC6A4 on chromosome 17 Hum Genet 1995 95: 677–680
Shen S, Battersby S, Weaver M, Clark E, Stephens K, Harmar AJ . Refined mapping of the human serotonin transporter (SLC6A4) gene within 17q11 adjacent to the CPD and NF1 genes Eur J Hum Genet 2000 8: 75–78
Lesch K-P, Balling U, Gross J, Strauss K, Wolozin B, Murphy D et al. Organization of the human serotonin transporter gene J Neural Transm 1994 95: 157–162
Bradley CC, Blakely RD . Alternative splicing of the human serotonin transporter gene J Neurochem 1997 69: 1356–1367
Heils A, Teufel A, Petri S, Stoeber G, Riederer P, Bengel D et al. Allelic variation of human serotonin transporter gene expression J Neurochem 1996 66: 2621–2624
Lesch K-P, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region Science 1996 274: 1527–1531
Fiskerstrand CE, Lovejoy EA, Quinn JP . An intronic polymorphic domain often associated with susceptibility to affective disorders has allele dependent differential enhancer activity in embryonic stem cells FEBS Lett 1999 458: 171–174
MacKenzie A, Quinn J . A serotonin transporter gene intron 2 polymorphic region, correlated with affective disorders, has allele-dependent differential enhancer-like properties in the mouse embryo Proc Natl Acad Sci USA 1999 96: 15251–15255
Veenstra-VanderWeele J, Anderson GM, Cook EH . Pharmacogenetics and the serotonin system: initial studies and future directions Eur J Pharmacol 2000 410: 165–181
Courtet P, Baud P, Abbar M, Boulenger J, Castelnau D, Mouthon D et al. Association between violent suicidal behavior and the low activity allele of the serotonin transporter allele Mol Psychiatry 2001 6: 338–341
Mossner R, Henneberg A, Schmitt A, Syagailo Y, Grassle M, Hennig T et al. Allelic variation of serotonin transporter expression is associated with depression in Parkinson's disease Mol Psychiatry 2001 6: 350–352
Mundo E, Walker M, Cate T, Macciardi F, Kennedy J . The role of the serotonin transporter protein gene in antidepressant-induced mania in bipolar disorder: preliminary findings Arch Gen Psychiatry 2001 58: 539–544
Cook EH Jr, Courchesne R, Lord C, Cox NJ, Yan S, Lincoln A et al. Evidence of linkage between the serotonin transporter and autistic disorder Mol Psychiatry 1997 2: 247–250
Klauck SM, Poustka F, Benner A, Lesch K-P, Poustka A . Serotonin transporter (5-HTT) gene variants associated with autism? Hum Molec Genet 1997 6: 2233–2238
Maestrini E, Lai C, Marlow A, Matthews N, Wallace S, Bailey A et al. Serotonin transporter (5-HTT) and gamma-aminobutyric acid receptor subunit beta3 (GABRB3) gene polymorphisms are not associated with autism in the IMGSA families Am J Med Genet 1999 88: 492–496
Persico AM, Militerni R, Bravaccio C, Schneider C, Melmed R, Conciatori M et al. Lack of association between serotonin transporter gene promoter variants and autistic disorder in two ethnically distinct samples Am J Med Genet 2000 96: 123–127
Yirmiya N, Pilowsky T, Nemanov L, Arbelle S, Feinsilver T, Fried I et al. Evidence for an association with the serotonin transporter promoter region polymorphism and autism Am J Med Genet (Neuropsychiatr Genet) 2001 105: 381–386
Tordjman S, Gutneckt L, Carlier M, Spitz E, Antoine C, Slama F et al. Role of the serotonin transporter in the behavioral expression of autism Mol Psychiatry 2001 6: 434–439
Zhong N, Ye L, Ju W, Tsiouris J, Cohen I, Brown W . 5-HTTLPR variants not associated with autistic spectrum disorders Neuro-genetics 1999 2: 129–131
Horikawa Y, Oda N, Cox NJ, Li X, Orho-Melander M, Hara M et al. Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus Nat Genet 2000 26: 163–175
Herr M, Dudbridge F, Zavattari P, Cucca F, Guja C, March R et al. Evaluation of fine mapping strategies for a multifactorial disease locus: systematic linkage and association analysis of IDDM1 in the HLA region on chromosome 6p21 Hum Mol Genet 2000 9: 1291–1301
Martin E, Lai E, Gilbert J, Rogala A, Afshari A, Riley J et al. SNPing away at complex diseases: analysis of single-nucleotide polymorphisms around APOE in Alzheimer disease Am J Hum Genet 2000 67: 383–394
Martin ER, Gilbert JR, Lai EH, Riley J, Rogala AR, Slotterbeck BD et al. Analysis of association at single nucleotide polymorphisms in the APOE region Genomics 2000 63: 7–12
International Molecular Genetic Study of Autism Consortium. A genome wide screen for autism: strong evidence for linkage to chromosomes 2q, 7q and 16p Am J Hum Genet 2001 69: 570–581
Lord C, Rutter M, Le Couteur A . Autism diagnostic interview – revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders J Autism Dev Disord 1994 24: 659–685
Lord C, Risi S, Lambrecht L, Cook EH Jr, Leventhal BL, DiLavore PC et al. The autism diagnostic observation schedule-generic: a standard measure of social and communication deficits associated with the spectrum of autism J Autism Dev Disord 2000 30: 205–223
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th edn) American Psychiatric Association Press: Washington, DC 1994
Chen X, Levine L, Kwok P . Fluorescence polarization in homogeneous nucleic acid analysis Genome Res 1999 9: 492–498
Cook E, Arora R, Anderson G, Berry-Kravis E, Yan S-Y, Yeoh H et al. Platelet serotonin studies in hyperserotonemic relatives of children with autistic disorder Life Sci 1993 52: 2005–2015
Glatt C, DeYoung J, Delgado S, Service S, Giacomini K, Edwards R et al. Screening a large reference sample to identify very low frequency sequence variants: comparisons between two genes Nature Genet 2001 27: 435–438
Lesch KP, Gross J, Franzek E, Wolozin BL, Riederer P, Murphy DL . Primary structure of the serotonin transporter in unipolar depression and bipolar disorder Biol Psychiatry 1995 37: 215–223
Altemus M, Murphy DL, Greenberg B, Lesch KP . Intact coding region of the serotonin transporter gene in obsessive-compulsive disorder Am J Med Genet 1996 67: 409–411
Di Bella D, Catalano M, Balling U, Smeraldi E, Lesch KP . Systematic screening for mutations in the coding region of the human serotonin transporter (5-HTT) gene using PCR and DGGE Am J Med Genet 1996 67: 541–545
Nickerson DA, Taylor SL, Fullerton SM, Weiss KM, Clark AG, Stengard JH et al. Sequence diversity and large-scale typing of SNPs in the human apolipoprotein E gene Genome Res 2000 10: 1532–1545
Xiong M, Jin L . Comparison of the power and accuracy of biallelic and microsatellite markers in population-based gene-mapping methods Am J Hum Genet 1999 64: 629–640
Ardlie K, Liu-Cordero SN, Eberle MA, Daly M, Barrett J, Winchester E et al. Lower-than-expected linkage disequilibrium between tightly linked markers in humans suggests a role for gene conversion Am J Hum Genet 2001 69: 582–589
Frisse L, Hudson RR, Bartoszewicz A, Wall JD, Donfack J, Di Rienzo A . Gene conversion and different population histories may explain the contrast between polymorphism and linkage disequilibrium levels Am J Hum Genet 2001 69: 831–843
Bromme D, Rossi AB, Smeekens SP, Anderson DC, Payan DG . Human bleomycin hydrolase: molecular cloning, sequencing, functional expression, and enzymatic characterization Biochemistry 1996 35: 6706–6714
Papassotiropoulos A, Bagli M, Jessen F, Frahnert C, Rao ML, Maier W et al. Confirmation of the association between bleomycin hydrolase genotype and Alzheimer's disease Mol Psychiatry 2000 5: 213–215
Mortensen OV, Thomassen M, Larsen MB, Whittemore SR, Wiborg O . Functional analysis of a novel human serotonin transporter gene promoter in immortalized raphe cells Brain Res Mol Brain Res 1999 68: 141–148
Acknowledgements
Zhi-Ying Yang and David Gonen provided expert technical assistance. Nicole Felix and Nelson Ayuyao provided database technical assistance. Jane Nofer, Marrea Winega, Susan Risi, Elisa Steele, Kathleen Kennedy Martin, Alan Lincoln, Senia Pizzo, and Richard Haas contributed to diagnostic assessments of probands. The study was supported in part by NIH R01 MH52223 (EHC, EC), K02 MH01389 (EHC), R01 NS19855 (EC), P01 HD35482 (EHC, CL), the Jean Young and Walden W Shaw Foundation (BLL), and the Irving B Harris Foundation (BLL). S-J Kim was a Daniel X Freedman Psychiatric Research Fellow during the course of this study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kim, SJ., Cox, N., Courchesne, R. et al. Transmission disequilibrium mapping at the serotonin transporter gene (SLC6A4) region in autistic disorder. Mol Psychiatry 7, 278–288 (2002). https://doi.org/10.1038/sj.mp.4001033
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.mp.4001033
Keywords
This article is cited by
-
Investigation of Genetic Polymorphism in Autism Spectrum Disorder: a Pathogenesis of the Neurodevelopmental Disorder
Advances in Neurodevelopmental Disorders (2022)
-
Advances in autism research, 2021: continuing to decipher the secrets of autism
Molecular Psychiatry (2021)
-
N-ethylmaleimide-sensitive factor interacts with the serotonin transporter and modulates its trafficking: implications for pathophysiology in autism
Molecular Autism (2014)
-
Genetic background modulates phenotypes of serotonin transporter Ala56 knock-in mice
Molecular Autism (2013)
-
Exploring the Relationship Between Autistic-Like Traits and ADHD Behaviors in Early Childhood: Findings from a Community Twin Study of 2-Year-Olds
Journal of Abnormal Child Psychology (2010)